Ninety One (UK)
AZN icon

Ninety One (UK)’s AstraZeneca AZN Stock Holding History

Ninety One (UK)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$47.3M Sell
290,212
-1,227,801
-81% -$205M 0.1% 123
2026
Q2 		$284M Sell
1,518,013
-529,006
-26% -$99.5M 0.64% 49
2026
Q1 		$397M Buy
+2,047,019
New +$395M 0.92% 33

Other funds holding AZN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Ninety One (UK)'s AZN Position: Q3 2026 in Review

Ninety One (UK) reduced its AstraZeneca (AZN) stake by 81% in Q3 2026, selling an estimated $205M and leaving 290,212 shares worth $47.3M. The position accounts for 0.1% of the portfolio, ranked #123.

Ninety One (UK) first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $397M in Q1 2026. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Ninety One (UK) held 290,212 shares of AstraZeneca worth $47.3M as of Q3 2026.
  • Ninety One (UK) sold 1,227,801 AstraZeneca shares in Q3 2026, an estimated $205M.
  • AstraZeneca made up 0.1% of Ninety One (UK)'s portfolio in Q3 2026, its #123 holding.
  • Ninety One (UK) first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
  • Ninety One (UK)'s AstraZeneca position peaked at $397M in Q1 2026.
  • 918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Ninety One (UK)'s 13F filing for Q3 2026, filed 15 Oct 2026.